Beranda › Serangan Jantung › Michigan
Uji klinis Serangan Jantung di Michigan
6 studi untuk Serangan Jantung mencari peserta di lokasi di Michigan.
Kota di Michigan
Teks studi resmi (Bahasa Inggris)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Paragon Health, Inc, Kalamazoo
- Michigan Kidney Consultants, PC, Pontiac
- St. Clair Nephrology Research, Roseville
- dan 1 lainnya
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT05485961An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- Henry Ford Hospital, Detroit
- AA Medical Research Center, Flint
- Metro Health Univ of MI Health, Wyoming
Menerima pesertaFase 3
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07517263OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Henry Ford Health System, Detroit
- Healthy Heart Cardiology, Grand Rapids
- MyMichigan Medical Center Midland - Clinical Research Department, Midland
- dan 2 lainnya
Menerima pesertaFase 3
Usia 50 hingga 105 · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT07136012AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
- Henry Ford Hospital, Detroit
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Jun 2026 · NCT06699056Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- Henry Ford Health System, Detroit
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Mar 2026 · NCT04774159Focused Orticumab Research for Treating Inflammation in Coronary Arteries
- Abcentra Investigational Site, Midland
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Jan 2026 · NCT06927739Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.